These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18318267)

  • 1. [Study on pricing and uptake rate of influenza vaccination for the elderly in Japan with a simple random sampling method].
    Hoshi SL; Kondo M; Okubo I
    Nihon Koshu Eisei Zasshi; 2008 Jan; 55(1):19-29. PubMed ID: 18318267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pricing and uptake rate of public funded pneumococcal vaccination for the elderly in Japan].
    Hoshi SL; Kondo M; Okubo I
    Nihon Koshu Eisei Zasshi; 2010 Jul; 57(7):505-13. PubMed ID: 20845712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of influenza vaccine subsidies for older adults on vaccination coverage and mortality before and during the COVID-19 pandemic: an ecological study in Japan.
    Ando T; Ibuka Y; Goto R; Haruta J; Le DD; Fujishima S
    Public Health; 2023 Nov; 224():152-158. PubMed ID: 37797561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does subsidy work? Price elasticity of demand for influenza vaccination among the elderly in Japan.
    Kondo M; Hoshi SL; Okubo I
    Health Policy; 2009 Aug; 91(3):269-76. PubMed ID: 19185945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in co-payments for influenza vaccine among the elderly, during the COVID-19 pandemic in Japan.
    Ando T; Maruyama T; Tamai A; Murakami T; Kido Y; Ishida T; Taya H; Haruta J; Sugiyama D; Fujishima S
    J Infect Chemother; 2022 Jul; 28(7):896-901. PubMed ID: 35339383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy evaluation for the subsidy for influenza vaccination in elderly.
    Ohkusa Y
    Vaccine; 2005 Mar; 23(17-18):2256-60. PubMed ID: 15755606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An economic evaluation of strategy for expanding influenza vaccination in Japan].
    Hara Y
    Nihon Rinsho; 2003 Nov; 61(11):2013-8. PubMed ID: 14619447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demand for pneumococcal vaccination under subsidy program for the elderly in Japan.
    Kondo M; Yamamura M; Hoshi SL; Okubo I
    BMC Health Serv Res; 2012 Sep; 12():313. PubMed ID: 22970727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out-of-pocket payments and community-wide health outcomes: an examination of influenza vaccination subsidies in Japan.
    Ibuka Y; Bessho S
    Health Econ Policy Law; 2016 Jul; 11(3):275-302. PubMed ID: 26894514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic evaluation for the prevention of cervical cancer by vaccination--from perspective of health insurance society and industry].
    Kawabayashi Y; Furuno M; Uchida M; Kawana T
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):493-8. PubMed ID: 23848018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsidy Programs for Seasonal Influenza Vaccination of Children and Pregnant Women in Japanese Municipalities.
    Shono A; Hoshi SL; Koshida R; Tanaka M; Kondo M
    Yakugaku Zasshi; 2024; 144(7):749-754. PubMed ID: 38945849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan.
    Hoshi SL; Kondo M; Okubo I
    PLoS One; 2015; 10(10):e0139140. PubMed ID: 26444287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a mass influenza vaccination campaign.
    Takahashi H; Tanaka Y; Ohyama T; Sunagawa T; Nakashima K; Schmid GP; Okabe N
    Jpn J Infect Dis; 2001 Oct; 54(5):184-8. PubMed ID: 11754156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduction of medical resources utilization by influenza vaccination for hospitalized elderly patients].
    Hara Y; Ikematsu H; Nabeshima A; Hagiwara A; Nobutomo K; Kashiwagi S
    Kansenshogaku Zasshi; 2001 Mar; 75(3):181-5. PubMed ID: 11321777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Yang J; Atkins KE; Feng L; Pang M; Zheng Y; Liu X; Cowling BJ; Yu H
    Vaccine; 2016 Nov; 34(47):5724-5735. PubMed ID: 27745951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors.
    Lv M; Fang R; Wu J; Pang X; Deng Y; Lei T; Xie Z
    Vaccine; 2016 Apr; 34(18):2135-40. PubMed ID: 26917011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the free vaccination campaign after the Great East Japan Earthquake.
    Naito T; Matsuda N; Tanei M; Watanabe Y; Watanabe A
    J Infect Chemother; 2014 Jul; 20(7):450-3. PubMed ID: 24767466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.